Pfizer's Covid treatment drug, Paxlovid, failed a late-stage study to determine if it could also be used prevent infections in those who aren't yet positive https://t.co/cVgitH7IFk— Bloomberg (@business) April 29, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


